Catalysts for Takeda Pharmaceuticals USA Inc
143 tracked
May 19, 2017
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 28, 2017
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 28, 2017
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 6, 2017
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 6, 2017
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 28, 2016
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Oct 14, 2016
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Oct 14, 2016
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Sep 7, 2016
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Aug 31, 2016
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jun 2, 2016
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 15, 2016
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 4, 2015
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 2, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Dec 1, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Aug 24, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
May 20, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 23, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 17, 2015
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 17, 2015
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Apr 17, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Mar 3, 2015
approval
ADDERALL XR 10 (AMPHETAMINE ASPARTATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Feb 3, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 30, 2015
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 30, 2015
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Jan 20, 2015
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Nov 14, 2014
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Oct 30, 2014
approval
VYVANSE (LISDEXAMFETAMINE DIMESYLATE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Sep 9, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→
Aug 15, 2014
approval
ICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approval
Takeda Pharmaceuticals USA Inc
→